Depixus is a developer of a single molecule genetic and epigenetic sequencing technology intended to offer extraction of genetic and epigenetic information from single molecules of DNA and RNA. The company's technology SIMDEQ (SIngle-molecule Magnetic DEtection and Quantification) permits a full genome or genomic region to be analyzed quickly and easily on a single integrated platform, with the investigator to specify the level of sequence and epigenetic detail required, enabling users with simple sample-preparation, sequential DNA fingerprinting, full-sequencing and epityping, together with a fast time-to-result and low operating costs.
Timeline
December 16, 2021
Depixus raises a $35,400,000 series A round.
November 2018
Depixus raises a $3,512,538 grant from EASME.
July 2016
Depixus raises a $86,481 grant from EASME.
2012
Depixus was founded by Gordon Hamilton.
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date